Skip to content

Oxygen Saturation and Caffeine Post-Discharge

Does the Use of Caffeine Post Discharge Normalize the Respiratory Patterns in Infants Born Earlier Than 35 Weeks? A Cohort Study

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02386046
Acronym
OCPDPS
Enrollment
144
Registered
2015-03-11
Start date
2015-02-28
Completion date
2017-10-31
Last updated
2019-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prematurity

Keywords

Caffeine use, Normative data

Brief summary

This study aims to determine normative values of oxygen saturation in late preterm infants, and evaluate the frequency of hypoxic events in infants requiring caffeine at discharge and those not requiring it.

Detailed description

Apnea of prematurity is a common morbidity among premature infants. Recent studies suggest an association between apnea and neurodevelopmental impairment. Our objectives are to determine normative values of oxygen saturation in late preterm infants -reference group. In infants born 28-35 weeks requiring caffeine- study group and infants born 28-35 weeks not requiring caffeine-control group we will be evaluating the frequency of hypoxic events. Recruitment time: February 2015 until December 2016. After consent a pulse oxymeter will be placed on the infant's right wrist. For those infants that will receive caffeine prior to discharge, this medication will be instituted after 12 hours of the initiation of the study and continue for the remaining of the hospitalization. For all other infants, the pulse oxymeter will be done continuously until discharge. After discharge, the recording will be done at home once a week until 46 weeks corrected age in the three groups. All the data will be reviewed by a blind observer to the groups from which that data comes. The data will be analyzed by a statistician. Normative values will be developed on the reference group until 46 weeks post conceptional age. Any medical problems encounter by the patients while on the study or in the following 6 months will be recorded to establish the safety of caffeine use at home and its discontinuation at 44 weeks post conceptional age.

Interventions

OTHERPulse oxymeter measurements

Pulse oxymeter measurements done at the hospital and upon discharge, weekly until 46 weeks postconceptional age

Sponsors

University of Calgary
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
26 Weeks to 46 Weeks
Healthy volunteers
Yes

Inclusion criteria

of infants admitted to NICU: 1. Gestational age at birth of \< or = 35 weeks 2. Families of infants that live in Calgary 3. Infants discharged home from PLC or South Health Campus (SHC) 4. Decision of treating team to start caffeine 5. No episodes of clinically significant apnea for a period of 3 to 5 days prior to discharge 6. Infant has access to reliable post-discharge follow up

Exclusion criteria

of all infants: 1. Active serious medical conditions other than apnea (Congenital Heart Disease (CHD), Chronic Lung Disease (CLD), symptomatic anemia). 2. Congenital disorders like Trisomies, genetic syndromes, midline defects, metabolic disorders.

Design outcomes

Primary

MeasureTime frameDescription
Pattern of Oxygen saturationUp to 46 weeks postconceptional ageMeasurements at hospital and weekly after discharge

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026